Proximie, a global health tech company, has raised $80 million, to scale up its virtual surgery platform.
The investment came in a series C round, which was led by Advent Life Sciences alongside participation from several new investors including Emerson Collective. Existing investors including F-Prime Capital and Global Ventures also participated. It brings the company’s total fundraise to date to $130 million.
The company, founded in 2016, features a tool that allows surgeons to connect virtually to any operating room, effectively widening access to surgical expertise in areas with low access. Its platform, which combines AI, machine learning and augmented reality, provides ORs with preoperative data and collaborative tools to deliver care, as well as postoperative content management tools. The investment will be used to accelerate the development of products and services and scale its operating system.
“Our vision is to democratize surgery through better data by connecting every OR and Cath Lab in the world,” Proximie founder and CEO Nadine Hachach-Haram, a consultant plastic surgeon, said in a press release. “We began this journey enabling surgeons to virtually join any OR. Now, we’re using this capability to digitize the operating room, bringing patients the collective expertise of the best surgeons in the world – where data collected and shared on Proximie can help them receive life-saving care, no matter where they live.”
The round closed on the heels of a year of rapid expansion for the company, driven by the pandemic, according to a press release. Proximie argues that supplying an “intelligent, digital layer” to the operating room saves health systems time, money and lives. It also accelerates the speed of surgeon training and reduces travel.
“The company is a perfect fit for our ethos of backing best-in-class innovative life sciences businesses that have the capability to positively impact human health and healthcare delivery in paradigm-changing ways,” said Shahzad Malik, MD, General Partner Advent Life Sciences, in a statement.
Proximie has been used at more than 500 hospitals worldwide and supported more than 13,000 surgeries in 2021, according to the company. It currently operates in more than 100 countries on five continents.